Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data

OBJECTIVES: A growing body of evidence suggests longer time between symptom onset and start of treatment affects breast cancer prognosis. To explore this association, the International Cancer Benchmarking Partnership Module 4 examined differences in breast cancer diagnostic pathways in 10 jurisdicti...

Descripción completa

Detalles Bibliográficos
Autores principales: Vedsted, Peter, Weller, David, Zalounina Falborg, Alina, Jensen, Henry, Kalsi, Jatinderpal, Brewster, David, Lin, Yulan, Gavin, Anna, Barisic, Andriana, Grunfeld, Eva, Lambe, Mats, Malmberg, Martin, Turner, Donna, Harland, Elizabeth, Hawryluk, Breann, Law, Rebecca-Jane, Neal, Richard D, White, Victoria, Bergin, Rebecca, Harrison, Samantha, Menon, Usha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756230/
https://www.ncbi.nlm.nih.gov/pubmed/36521881
http://dx.doi.org/10.1136/bmjopen-2021-059669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756230/
https://www.ncbi.nlm.nih.gov/pubmed/36521881
http://dx.doi.org/10.1136/bmjopen-2021-059669

Ejemplares similares